These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21833789)

  • 1. Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.
    Hirose M; Tozawa K; Okada A; Hamamoto S; Higashibata Y; Gao B; Hayashi Y; Shimizu H; Kubota Y; Yasui T; Kohri K
    Urol Res; 2012 Apr; 40(2):121-9. PubMed ID: 21833789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney.
    Okada A; Nomura S; Saeki Y; Higashibata Y; Hamamoto S; Hirose M; Itoh Y; Yasui T; Tozawa K; Kohri K
    J Bone Miner Res; 2008 Oct; 23(10):1629-37. PubMed ID: 18505365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN transgenic and OPN knockout mice.
    Hamamoto S; Nomura S; Yasui T; Okada A; Hirose M; Shimizu H; Itoh Y; Tozawa K; Kohri K
    J Bone Miner Res; 2010 Dec; 25(12):2712-23. PubMed ID: 19453257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice.
    Hamamoto S; Yasui T; Okada A; Hirose M; Matsui Y; Kon S; Sakai F; Kojima Y; Hayashi Y; Tozawa K; Uede T; Kohri K
    J Bone Miner Res; 2011 Dec; 26(12):2967-77. PubMed ID: 21898593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney.
    Hirose M; Yasui T; Okada A; Hamamoto S; Shimizu H; Itoh Y; Tozawa K; Kohri K
    Int J Urol; 2010 Jan; 17(1):83-92. PubMed ID: 19919640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation.
    Okada A; Yasui T; Fujii Y; Niimi K; Hamamoto S; Hirose M; Kojima Y; Itoh Y; Tozawa K; Hayashi Y; Kohri K
    J Bone Miner Res; 2010 Dec; 25(12):2701-11. PubMed ID: 20577968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse.
    Hirose M; Tozawa K; Okada A; Hamamoto S; Shimizu H; Kubota Y; Itoh Y; Yasui T; Kohri K
    Urol Res; 2008 Aug; 36(3-4):139-47. PubMed ID: 18542940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.
    Vernon HJ; Osborne C; Tzortzaki EG; Yang M; Chen J; Rittling SR; Denhardt DT; Buyske S; Bledsoe SB; Evan AP; Fairbanks L; Simmonds HA; Tischfield JA; Sahota A
    Kidney Int; 2005 Sep; 68(3):938-47. PubMed ID: 16105024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.
    Okada A; Nomura S; Higashibata Y; Hirose M; Gao B; Yoshimura M; Itoh Y; Yasui T; Tozawa K; Kohri K
    Urol Res; 2007 Apr; 35(2):89-99. PubMed ID: 17393196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.
    Mo L; Huang HY; Zhu XH; Shapiro E; Hasty DL; Wu XR
    Kidney Int; 2004 Sep; 66(3):1159-66. PubMed ID: 15327412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys.
    Asselman M; Verhulst A; De Broe ME; Verkoelen CF
    J Am Soc Nephrol; 2003 Dec; 14(12):3155-66. PubMed ID: 14638914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydration status affects osteopontin expression in the rat kidney.
    Lee SY; Lee SJ; Piao HL; Yang SY; Weiner ID; Kim J; Han KH
    J Vet Sci; 2016 Sep; 17(3):269-77. PubMed ID: 26645343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L; Liaw L; Evan AP; Sommer AJ; Lieske JC; Wu XR
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat.
    Zhai W; Zheng J; Yao X; Peng B; Liu M; Huang J; Wang G; Xu Y
    BMC Complement Altern Med; 2013 Sep; 13():228. PubMed ID: 24044655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.
    Chien YC; Masica DL; Gray JJ; Nguyen S; Vali H; McKee MD
    J Biol Chem; 2009 Aug; 284(35):23491-501. PubMed ID: 19581305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
    Wesson JA; Johnson RJ; Mazzali M; Beshensky AM; Stietz S; Giachelli C; Liaw L; Alpers CE; Couser WG; Kleinman JG; Hughes J
    J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium.
    Verhulst A; Asselman M; Persy VP; Schepers MS; Helbert MF; Verkoelen CF; De Broe ME
    J Am Soc Nephrol; 2003 Jan; 14(1):107-15. PubMed ID: 12506143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin and calcium stone formation.
    Kleinman JG; Wesson JA; Hughes J
    Nephron Physiol; 2004; 98(2):p43-7. PubMed ID: 15499214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
    Yamate T; Kohri K; Umekawa T; Iguchi M; Kurita T
    J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure.
    Umekawa T; Yamate T; Amasaki N; Kohri K; Kurita T
    Urol Int; 1995; 55(1):6-10. PubMed ID: 7571189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.